Nociceptin/OrphaninFQ (N/OFQ) and Nociceptin Orphan Peptide (NOP) receptors represent an endogenous system modulating gastrointestinal functions and inflammation. We investigated the effect of the peripheral administration of the agonist N/OFQ (0.02-0.2-2-20 nmol/kg) and the antagonist UFP-101 (1-3-10 nmol/kg) on some inflammatory variables in a rat model of colitis induced by intracolonic (IC) instillation of TNBS (2,4,6 trinitrobenzensulfonic acid) (60 mg/kg, IC). Male Wistar rats received two intraperitoneal (IP) injections per day of N/OFQ, or UFP-101, or saline for three days after induction of colitis. Four days after TNBS, animals were sacrificed and colonic histological damage, myeloperoxidase (MPO) activity, cytokine (IL-1 and IL-10) levels were evaluated. N/OFQ plasmatic concentration was assessed by radioimmunoassay. TNBS increased all the inflammatory variables considered. In colitic rats, N/OFQ, at 0.02 and 0.2nmol/kg, improved microscopic damage and MPO activity, and decreased IL-1 levelsin comparison with TNBS group, whereas at the highest dose (20 nmol/kg) worsened colitis. UFP-101, which at dose of 3 and 10 nmol/kg increased inflammation, at a dose of 1 nmol/kg, without intrinsic activity, antagonized the protective effect of N/OFQ (0.2 nmol/kg) on colitis. N/OFQ plasmatic levels, which were not modified in TNBS-treated rats compared with controls, decreased in rats treated with UFP-101 at the doses (3 and 10 nmol/kg) that worsen colitis. In conclusion: 1) peripheral low doses of N/OFQ have immunosuppressive and anti-inflammatory effects on TNBS colitis in rats; 2) N/OFQ, at a dose 1000-10000 fold higher than those that protect, worsens colitis. 3) The endogenous peripheral N/OFQergic system plays a protective role in this experimental pathological condition.

Effect of agonist (Nociceptin/Orphanin FQ) and antagonist (UFP-101) of the NOP receptor system in a rat model of experimental colitis / Petrella, Carla; Giuli, Chiara; H., Eutamene; C., Cartier; M., Leveque; A., Bedini; S., Spampinato; L., Bueno; V., Theodorou; Broccardo, Maria; Improta, Giovanna; S., Agostini. - (2012). ((Intervento presentato al convegno 6th European Congress of Pharmacology EPHAR tenutosi a Granada (Spain) nel July, 17-20.

Effect of agonist (Nociceptin/Orphanin FQ) and antagonist (UFP-101) of the NOP receptor system in a rat model of experimental colitis

PETRELLA, CARLA;GIULI, CHIARA;BROCCARDO, Maria;IMPROTA, Giovanna;
2012

Abstract

Nociceptin/OrphaninFQ (N/OFQ) and Nociceptin Orphan Peptide (NOP) receptors represent an endogenous system modulating gastrointestinal functions and inflammation. We investigated the effect of the peripheral administration of the agonist N/OFQ (0.02-0.2-2-20 nmol/kg) and the antagonist UFP-101 (1-3-10 nmol/kg) on some inflammatory variables in a rat model of colitis induced by intracolonic (IC) instillation of TNBS (2,4,6 trinitrobenzensulfonic acid) (60 mg/kg, IC). Male Wistar rats received two intraperitoneal (IP) injections per day of N/OFQ, or UFP-101, or saline for three days after induction of colitis. Four days after TNBS, animals were sacrificed and colonic histological damage, myeloperoxidase (MPO) activity, cytokine (IL-1 and IL-10) levels were evaluated. N/OFQ plasmatic concentration was assessed by radioimmunoassay. TNBS increased all the inflammatory variables considered. In colitic rats, N/OFQ, at 0.02 and 0.2nmol/kg, improved microscopic damage and MPO activity, and decreased IL-1 levelsin comparison with TNBS group, whereas at the highest dose (20 nmol/kg) worsened colitis. UFP-101, which at dose of 3 and 10 nmol/kg increased inflammation, at a dose of 1 nmol/kg, without intrinsic activity, antagonized the protective effect of N/OFQ (0.2 nmol/kg) on colitis. N/OFQ plasmatic levels, which were not modified in TNBS-treated rats compared with controls, decreased in rats treated with UFP-101 at the doses (3 and 10 nmol/kg) that worsen colitis. In conclusion: 1) peripheral low doses of N/OFQ have immunosuppressive and anti-inflammatory effects on TNBS colitis in rats; 2) N/OFQ, at a dose 1000-10000 fold higher than those that protect, worsens colitis. 3) The endogenous peripheral N/OFQergic system plays a protective role in this experimental pathological condition.
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/514800
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact